chartexchange

Immix Biopharma’s NXC-201 NEXICART-2 Interim Clinical Trial Results Selected for Oral Presentation at ASH 2026

GlobeNewswire Inc. | Nov 4, 2026 9:15 AM EST

–  Data will be presented on Monday, December 14, 2026 at 11:15 AM CDT –

Read original article